Paper20725732
[New biologics and orally available compounds. What is still in the pipeline?].
Grünke M and 3 others. Z Rheumatol, 2010. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [New biologics and orally available compounds. What is still in the pipeline?]. Papers, record 20725732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20725732
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antirheumatic Agents | Major topic |
| Biological Products | Major topic |
| Rheumatic Diseases | Major topic |
| Rheumatology | Major topic |
| Administration, Oral | |
| Humans |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19587388 | Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/19587388 | PubMed |
| 2 | 20065634 | Denosumab. | MAbs | 2009 | https://conductscience.org/library/papers/20065634 | PubMed |
| 3 | 11549370 | Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. | Arthritis Res | 2001 | https://conductscience.org/library/papers/11549370 | PubMed |
| 4 | 20391509 | Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis. | Arthritis Care Res (Hoboken) | 2010 | https://conductscience.org/library/papers/20391509 | PubMed |
| 5 | 19424068 | Denosumab update. | Curr Opin Rheumatol | 2009 | https://conductscience.org/library/papers/19424068 | PubMed |
| 6 | 18438830 | Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/18438830 | PubMed |
| 7 | 10632676 | Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/10632676 | PubMed |
| 8 | 19256507 | Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor. | J Med Chem | 2009 | https://conductscience.org/library/papers/19256507 | PubMed |
| 9 | 16780833 | The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16780833 | PubMed |
| 10 | 18551128 | Colony-stimulating factors in inflammation and autoimmunity. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18551128 | PubMed |
| 11 | 7932447 | Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor. | J Rheumatol | 1994 | https://conductscience.org/library/papers/7932447 | PubMed |
| 12 | 8049356 | Evidence for GM-CSF receptor expression in synovial tissue. An analysis by semi-quantitative polymerase chain reaction on rheumatoid arthritis and osteoarthritis synovial biopsies. | Eur Cytokine Netw | 1994 | https://conductscience.org/library/papers/8049356 | PubMed |
| 13 | 20506254 | Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20506254 | PubMed |
| 14 | 19565475 | The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo. | Arthritis Rheum | 2009 | https://conductscience.org/library/papers/19565475 | PubMed |
| 15 | 9227165 | Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. | Ann Rheum Dis | 1997 | https://conductscience.org/library/papers/9227165 | PubMed |
| 16 | 20391513 | Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients. | Arthritis Care Res (Hoboken) | 2010 | https://conductscience.org/library/papers/20391513 | PubMed |
| 17 | 20164774 | Kinase inhibitors: a new approach to rheumatoid arthritis treatment. | Curr Opin Rheumatol | 2010 | https://conductscience.org/library/papers/20164774 | PubMed |
| 18 | 14613291 | Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. | Arthritis Rheum | 2003 | https://conductscience.org/library/papers/14613291 | PubMed |
| 19 | 17062647 | Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis. | Rheumatology (Oxford) | 2007 | https://conductscience.org/library/papers/17062647 | PubMed |
| 20 | 18975322 | Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/18975322 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 21590474 | [Therapeutic strategies in rheumatoid arthritis]. | Internist (Berl) | 2011 | https://conductscience.org/library/papers/21590474 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20725732
GET https://conductscience.org/api/papers/v1/20725732/references?page=2